Astigmatism Market Summary
Factors Affecting Astigmatism Market Growth
Rising Prevalence of Refractive Errors
The increasing global burden of refractive disorders, including astigmatism, is a primary driver of market growth. A significant portion of the population experiences vision-related issues, leading to higher demand for corrective solutions such as glasses, contact lenses, and surgeries.
Growing Screen Time and Digital Eye Strain
The surge in digital device usage has contributed to visual impairments, including astigmatism. Prolonged exposure to screens is associated with eye strain and worsening vision conditions, thereby increasing the need for diagnosis and treatment solutions.
Technological Advancements in Vision Correction
Innovations such as toric intraocular lenses (IOLs), wavefront-guided LASIK, and customized contact lenses are improving treatment accuracy and patient outcomes. These advancements enhance adoption rates and expand the market scope.
Increasing Adoption of Laser Eye Surgeries
Procedures like LASIK and SMILE are gaining popularity due to their effectiveness, quick recovery time, and long-term benefits. The growing preference for surgical correction is significantly contributing to market expansion.
Rising Awareness and Early Diagnosis
Improved awareness about eye health and the importance of early detection has led to increased screening rates. Early diagnosis enables timely treatment, boosting demand for ophthalmic products and services.
Aging Population
The global rise in the elderly population is a major growth driver, as age-related changes in the eye increase the likelihood of astigmatism and other vision disorders. This demographic trend fuels sustained demand for corrective solutions.
Expansion of Eye Care Infrastructure
Growth in ophthalmic clinics, optical retail chains, and specialized eye care centers has improved accessibility to diagnosis and treatment. This expansion supports higher patient volumes and market growth.
Increasing Demand for Contact Lenses and Eyewear
The rising preference for convenient and aesthetic vision correction options, including toric contact lenses and advanced spectacles, is accelerating product adoption and boosting market revenues.
Genetic and Environmental Factors
Genetic predisposition and environmental influences, such as eye injuries or corneal changes, contribute to the incidence of astigmatism, thereby increasing the patient pool and treatment demand.
Investment in R&D and Product Innovation
Significant investments by key players in research and development are leading to new product launches and improved treatment modalities, strengthening market competitiveness and growth potential.
DelveInsight's "Astigmatism Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Astigmatism, historical and forecasted epidemiology as well as the Astigmatism market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Astigmatism market report provides current treatment practices, emerging drugs, Astigmatism market share of the individual therapies, current and forecasted Astigmatism market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Astigmatism treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Astigmatism market.
Scope of the Astigmatism Market Report | |
|
Study Period |
2020 to 2034 |
|
Forecast Period |
2024 to 2034 |
|
Geographies Covered |
The US, EU4 (Germany, France, Italy, and Spain) and UK, and Japan |
|
Astigmatism Market |
|
|
Astigmatism Market Size | |
|
Astigmatism Companies | Novartis AG, SEA VISION S.r.l, Johnson & Johnson Services, Inc, Bausch and Lomb, CooperVision, Carl Zeiss Meditec AG, Seed Co., Ltd, Essilor Group, and others. |
Astigmatism Disease Understanding and Treatment Algorithm
Astigmatism is a common refractive error of the eye in which the cornea or lens has an irregular shape, preventing light from focusing evenly on the retina. Instead of having a perfectly round curvature, the cornea is shaped more like an oval, leading to blurred or distorted vision at all distances.
Astigmatism can occur alone or alongside other refractive errors such as myopia (nearsightedness) or hyperopia (farsightedness). It is typically present from birth but may also develop later due to eye injury, surgery, or disease. The condition is generally not progressive but can change gradually over time.
There are two main types:
- Corneal astigmatism – caused by irregularities in the cornea
- Lenticular astigmatism – caused by irregularities in the eye’s lens
Astigmatism is highly prevalent worldwide and is one of the leading causes of visual impairment, but it is easily manageable with appropriate corrective measures.
Astigmatism Symptoms
Symptoms of astigmatism can vary depending on severity, but commonly include:
- Blurred or distorted vision at both near and far distances
- Eye strain or discomfort, especially after prolonged visual tasks
- Frequent headaches due to visual stress
- Difficulty seeing at night (poor night vision)
- Squinting to improve clarity
- Double vision (in some cases)
In children, symptoms may be subtle and can include:
- Poor academic performance
- Frequent eye rubbing
- Lack of attention due to visual discomfort
Mild astigmatism may not produce noticeable symptoms, which is why routine eye examinations are important for early detection.
Astigmatism Diagnosis
Astigmatism is diagnosed through a comprehensive eye examination conducted by an optometrist or ophthalmologist. Key diagnostic methods include:
1. Visual Acuity Test
Measures how clearly a person can see at various distances using an eye chart.
2. Refraction Test
Determines the exact prescription needed to correct vision using a device called a phoropter.
3. Keratometry
Measures the curvature of the cornea to detect irregularities that indicate astigmatism.
4. Corneal Topography
An advanced imaging technique that maps the surface curvature of the cornea in detail, providing precise information about astigmatism severity and type.
5. Slit-Lamp Examination
Uses a specialized microscope to examine the eye’s structures and identify underlying causes.
Early diagnosis is essential for effective management and prevention of complications such as amblyopia (lazy eye), especially in children.
Astigmatism Epidemiology
The Astigmatism epidemiology section provides insights about the historical and current Astigmatism patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Astigmatism market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings from Astigmatism Epidemiology Forecast and Analysis
The disease epidemiology covered in the report provides historical as well as forecasted Astigmatism epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
Country Wise- Astigmatism Epidemiology
The epidemiology segment also provides the Astigmatism epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Astigmatism Drugs Analysis
The drug chapter segment of the Astigmatism report encloses the detailed analysis of Astigmatism marketed drugs and late-stage (Phase-III and Phase-II) Astigmatism pipeline drugs. It also helps to understand the Astigmatism clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Astigmatism Marketed Drugs
The Astigmatism market report provides the details of the marketed products/off-label treatments available for Astigmatism treatment.
Astigmatism Emerging Drugs
The Astigmatism market report provides the details of the emerging therapies under the late and mid-stage of development for Astigmatism treatment.
Astigmatism Market Outlook
The Astigmatism market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Astigmatism market trends by analyzing the impact of current Astigmatism therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of Astigmatism market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Astigmatism market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Astigmatism market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Findings from Astigmatism Market Forecast and Analysis
This section includes a glimpse of the Astigmatism market in 7MM.
Astigmatism Regional Analysis
The United States Astigmatism Market Outlook
This section provides the total Astigmatism market size and market size by therapies in the United States.
EU-5 Countries Astigmatism Market Outlook
The total Astigmatism market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.
Japan Astigmatism Market Outlook
The total Astigmatism market size and market size by therapies in Japan is also mentioned.
Astigmatism Drugs Uptake
This section focuses on the rate of uptake of the potential Astigmatism drugs recently launched in the Astigmatism market or expected to get launched in the market during the study period 2019-2032. The analysis covers Astigmatism market uptake by drugs; patient uptake by therapies; and sales of each drug.
Astigmatism Drugs Uptake helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and allow the comparison of the drugs on the basis of Astigmatism market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Astigmatism Clinical Trial Activities
The Astigmatism market report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Astigmatism key players involved in developing targeted therapeutics.
Astigmatism Pipeline Development Activities
The Astigmatism market report covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Astigmatism emerging therapies.
Reimbursement Scenario in Astigmatism
Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.
Latest KOL- Views on Astigmatism Market
To keep up with current Astigmatism market trends, we take KOLs and SMEs ' opinion working in the Astigmatism domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Astigmatism market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.
Astigmatism Competitive Intelligence Analysis
We perform Competitive and Market Intelligence analysis of the Astigmatism Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.
Scope of the Astigmatism Market Report
- The Astigmatism Market report covers the descriptive overview of Astigmatism, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Astigmatism epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Astigmatism is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of the Astigmatism market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The Astigmatism Market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Astigmatism market
Astigmatism Market Report Highlights
- In the coming years, the Astigmatism market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
- The companies and academics are working to assess challenges and seek opportunities that could influence Astigmatism R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
- Major Astigmatism companies are involved in developing therapies for Astigmatism. The launch of emerging therapies will significantly impact the Astigmatism market
- A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Astigmatism
- Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
Astigmatism Market Report Insights
- Astigmatism Patient Population
- Therapeutic Approaches
- Astigmatism Pipeline Analysis
- Astigmatism Market Size
- Astigmatism Market Trends
- Astigmatism Market Opportunities
- Impact of upcoming Astigmatism Therapies
Astigmatism Market Report Key Strengths
- 11 Years Forecast
- 7MM Coverage
- Astigmatism Epidemiology Segmentation
- Key Cross Competition
- Highly Analyzed Astigmatism Market
- Astigmatism Drugs Uptake
Astigmatism Market Report Assessment
- Current Treatment Practices
- Astigmatism Unmet Needs
- Astigmatism Pipeline Product Profiles
- Astigmatism Market Attractiveness
- Astigmatism Market Drivers
- Astigmatism Market Barriers
Key Questions Answered in Astigmatism Market
Astigmatism Market Insights
- What was the Astigmatism drug class share (%) distribution in 2019 and how it would look like in 2032?
- What would be the Astigmatism total market size as well as market size by therapies across the 7MM during the forecast period (2019-2032)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Astigmatism market size during the forecast period (2019-2032)?
- At what CAGR, the Astigmatism market is expected to grow by 7MM during the forecast period (2019-2032)?
- What would be the Astigmatism market outlook across the 7MM during the forecast period (2019-2032)?
- What would be the Astigmatism market growth till 2032, and what will be the resultant market Size in the year 2032?
- How would the unmet needs affect the Astigmatism Market dynamics and subsequent analysis of the associated trends?
Astigmatism Epidemiology Insights
- What are the disease risk, burden, and regional/ethnic differences of the Astigmatism?
- What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- What is the historical Astigmatism patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- What would be the forecasted patient pool of Astigmatism in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Astigmatism?
- Out of all 7MM countries, which country would have the highest prevalent population of Astigmatism during the forecast period (2019-2032)?
- At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
Current Treatment Scenario, Marketed Drugs and Emerging Therapies:
- What are the current options for the Astigmatism treatment in addition to the approved therapies?
- What are the current treatment guidelines for the treatment of Astigmatism in the USA, Europe, and Japan?
- What are the Astigmatism marketed drugs and their respective MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
- How many Astigmatism companies are developing therapies for the treatment of Astigmatism?
- How many Astigmatism therapies are in-development by each company for Astigmatism treatment?
- How many are emerging Astigmatism therapies in mid-stage, and late stage of development for Astigmatism treatment?
- What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Astigmatism therapies?
- What are the recent novel therapies, targets, mechanisms of action and technologies being developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Astigmatism and their status?
- What are the current challenges faced in Astigmatism drug development?
- What are the key designations that have been granted for the emerging therapies for Astigmatism?
- What are the global historical and forecasted Astigmatism market?
Reasons to buy the Astigmatism Market Report
- The Astigmatism Market report will help in developing business strategies by understanding trends shaping and driving the Astigmatism market
- To understand the future market competition in the Astigmatism market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Astigmatism in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Astigmatism market
- To understand the future market competition in the Astigmatism market
